Senior executive to leave Advancis
9th Sep 2005, 18:40 GMT
Advancis Pharmaceutical continues to streamline its operations. The latest announcement is that its senior vice president and chief business officer, Kevin Sly, will leave the company Sept. 15.
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- Synbiotics flu test gets OK from USDA
- Mesa Lab's numbers up
- Reliance Steel to offer $600M in notes
- Biotech firm expanding, completes office relocation
- Spectrum Pharmaceuticals settles with GlaxoSmithKline
- Study: Bioenergy sugar product useful for chronic fatigue syndrome
- IBT Labs will spend $2M to expand division
- InnoCentive to help push $1M prize for discoveries in ALS
- Mercury, BU team says biotech app cuts processing time to minutes
- Omnicare to pay $49.5M in civil settlement